Suppr超能文献

FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis.

作者信息

Kim Jieun, Seki Ekihiro

机构信息

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

出版信息

Cell Mol Gastroenterol Hepatol. 2023;15(4):1018-1019. doi: 10.1016/j.jcmgh.2022.12.018. Epub 2023 Jan 18.

Abstract
摘要

相似文献

1
FAP: Not Just a Biomarker but Druggable Target in Liver Fibrosis.
Cell Mol Gastroenterol Hepatol. 2023;15(4):1018-1019. doi: 10.1016/j.jcmgh.2022.12.018. Epub 2023 Jan 18.
2
Fibroblast activation protein in liver fibrosis.
Front Biosci (Landmark Ed). 2019 Jan 1;24(1):1-17. doi: 10.2741/4706.
3
Selective Homogeneous Assay for Circulating Endopeptidase Fibroblast Activation Protein (FAP).
Sci Rep. 2017 Oct 2;7(1):12524. doi: 10.1038/s41598-017-12900-8.
9
Fibroblast activation protein and chronic liver disease.
Front Biosci. 2008 Jan 1;13:3168-80. doi: 10.2741/2918.
10
Blood reelin in the progression of chronic liver disease.
Adv Med Sci. 2021 Mar;66(1):148-154. doi: 10.1016/j.advms.2021.01.006. Epub 2021 Feb 6.

引用本文的文献

4
CAR-macrophage: Breaking new ground in cellular immunotherapy.
Front Cell Dev Biol. 2024 Oct 3;12:1464218. doi: 10.3389/fcell.2024.1464218. eCollection 2024.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验